Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Pyxis Oncology, Inc. (PYXS) Debt to Capital Ratio data is not available.
| Income Statement Financials | |
-- |
|
$-23.27M |
|
-- |
|
-- |
|
$24.36M |
|
$-24.36M |
|
$1.09M |
|
$-23.27M |
|
$-23.27M |
|
$-23.27M |
|
$-23.27M |
|
$-23.27M |
|
$-23.27M |
|
$-24.36M |
|
$-24.14M |
|
63.47M |
|
63.47M |
|
$-0.37 |
|
$-0.37 |
|
| Balance Sheet Financials | |
$45.57M |
|
$7.54M |
|
$18.73M |
|
$64.30M |
|
$16.53M |
|
-- |
|
$16.50M |
|
$33.03M |
|
$31.27M |
|
$31.27M |
|
$31.27M |
|
62.83M |
|
| Cash Flow Statement Financials | |
$-26.00M |
|
$16.37M |
|
$-0.03M |
|
$16.89M |
|
$7.24M |
|
$-9.66M |
|
$1.21M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.76 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-26.00M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-74.43% |
|
-74.43% |
|
-36.19% |
|
-74.43% |
|
$0.50 |
|
$-0.41 |
|
$-0.41 |
|